We are live on !
Find out more
Philip James Wealth Mangement Portfolio holdings
AUM
$888M
Turnover
15.57%
1-Year Est. Return
36.11%
This Fund
S&P 500
This Quarter Est. Return
+8.29%
1 Year Est. Return
+36.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$888M
AUM Growth
+$18.7M
(+2.2%)
Cap. Flow
-$23.3M
Cap. Flow % of AUM
Cap. Flow %
-2.62%
Top 10 Holdings %
Top 10 Hldgs %
53.95%
Holding
167
New
10
Increased
19
Reduced
109
Closed
16
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$25.3M |
| 2 |
General Mills
GIS
|
+$10.7M |
| 3 |
Novo Nordisk
NVO
|
+$7.97M |
| 4 |
Check Point Software Technologies
CHKP
|
+$6.87M |
| 5 |
The Kraft Heinz Company
KHC
|
+$4.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$44.3M |
| 2 |
Qualcomm
QCOM
|
+$9.28M |
| 3 |
FedEx
FDX
|
+$7.64M |
| 4 |
Occidental Petroleum Corp Warrants
OXY.WS
|
+$5M |
| 5 |
ExxonMobil
XOM
|
+$2.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.12% |
| 2 | Miscellaneous | 16.13% |
| 3 | Healthcare | 13.23% |
| 4 | Energy | 12.6% |
| 5 | Consumer Staples | 10.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class B
BRK.B
$1.14T
| $218M | 24.5% |
434,980
-1,401
| -0.3% | -$674K |
2023 Q4
10 quarters
|
|
|
2
ExxonMobil
XOM
$733B
| $57.9M | 6.52% |
423,584
-16,656
| -4% | -$2.49M |
2024 Q3
7 quarters
|
|
3
Chubb
CB
$137B
| $35.5M | 4% |
104,308
+13,009
| +14% | +$4.24M |
2023 Q4
10 quarters
|
|
|
4
Occidental Petroleum Corp Warrants
OXY.WS
$38.5B
| $27.3M | 3.07% |
1,023,537
-143,804
| -12% | -$5M |
2024 Q3
7 quarters
|
|
|
5
Qualcomm
QCOM
$185B
| $27M | 3.04% |
146,026
-49,624
| -25% | -$9.28M |
2024 Q1
9 quarters
|
|
|
6
Abbott
ABT
$180B
| $25.6M | 2.88% |
281,731
+277,542
| +6,625% | +$25.3M |
2024 Q3
7 quarters
|
|
|
7
Intel
INTC
$486B
| $22.8M | 2.57% |
163,366
-438,416
| -73% | -$44.3M |
2024 Q3
7 quarters
|
|
|
8
General Mills
GIS
$17.4B
| $22.4M | 2.52% |
643,999
+308,865
| +92% | +$10.7M |
2024 Q3
7 quarters
|
|
9
Merck
MRK
$354B
| $22.3M | 2.51% |
173,727
-10,855
| -6% | -$1.27M |
2024 Q3
7 quarters
|
|
10
Johnson & Johnson
JNJ
$612B
| $20.8M | 2.34% |
81,906
-2,239
| -3% | -$522K |
2023 Q4
10 quarters
|
|
|
11
Occidental Petroleum
OXY
$62.7B
| $20.4M | 2.29% |
419,153
-4,153
| -1% | -$236K |
2024 Q3
7 quarters
|
|
12
Rocket Companies
RKT
$30.3B
| $13.7M | 1.54% |
867,907
+123,526
| +17% | +$1.78M |
2024 Q3
7 quarters
|
|
13
PepsiCo
PEP
$182B
| $13.1M | 1.47% |
96,392
+15,771
| +20% | +$2.36M |
2024 Q3
7 quarters
|
|
|
14
Novo Nordisk
NVO
$170B
| $12.9M | 1.46% |
269,741
+185,606
| +221% | +$7.97M |
2026 Q1
1 quarter
|
|
15
Altria Group
MO
$124B
| $12.4M | 1.39% |
171,890
-22,690
| -12% | -$1.58M |
2023 Q4
10 quarters
|
|
16
PayPal
PYPL
$48.3B
| $12.3M | 1.38% |
283,951
+68,550
| +32% | +$3.12M |
2024 Q3
7 quarters
|
|
17
Vanguard Morningstar Total Stock Market ETF
VTI
$692B
| $11.5M | 1.29% |
31,098
-1,150
| -4% | -$411K |
2023 Q4
10 quarters
|
|
18
Pfizer
PFE
$168B
| $10.7M | 1.2% |
443,426
+31,652
| +8% | +$828K |
2024 Q3
7 quarters
|
|
19
Chevron
CVX
$440B
| $10.3M | 1.16% |
62,112
-3,090
| -5% | -$575K |
2024 Q3
7 quarters
|
|
20
iShares Core Dividend Growth ETF
DGRO
$43.7B
| $9.49M | 1.07% |
125,283
-3,678
| -3% | -$271K |
2023 Q4
10 quarters
|
|
|
21
The Kraft Heinz Company
KHC
$27.5B
| $8.85M | 1% |
374,700
+205,545
| +122% | +$4.74M |
2024 Q3
7 quarters
|
|
22
JPMorgan Hedged Equity Laddered Overlay ETF
HELO
$4.87B
| $8.44M | 0.95% |
124,823
-6,311
| -5% | -$424K |
2023 Q4
10 quarters
|
|
23
Diageo
DEO
$52B
| $8.29M | 0.93% |
103,195
+19,790
| +24% | +$1.6M |
2025 Q1
5 quarters
|
|
24
VanEck Morningstar Wide Moat ETF
MOAT
$11.7B
| $8.27M | 0.93% |
79,605
-2,012
| -2% | -$203K |
2023 Q4
10 quarters
|
|
25
British American Tobacco
BTI
$126B
| $7.88M | 0.89% |
127,523
-20,215
| -14% | -$1.22M |
2024 Q3
7 quarters
|
|
Similar funds
IBOK
Philip James Wealth Mangement's Q2 2026 Portfolio in Review
As of Q2 2026, Philip James Wealth Mangement held 167 positions worth $888M, up 2.2% from $870M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Philip James Wealth Mangement's Q2 2026 filing shows 10 new, 19 increased, 109 reduced and 16 closed positions. Its largest new stake was GE HealthCare: 41,921 shares worth $2.68M. The largest sale was Intel, an estimated $44.3M.
By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 32% a quarter earlier, followed by Miscellaneous and Healthcare.
- Philip James Wealth Mangement's largest Q2 2026 buy was GE HealthCare: 41,921 shares worth $2.68M.
- Philip James Wealth Mangement added most to Abbott in Q2 2026, an estimated $25.3M increase.
- Philip James Wealth Mangement's biggest Q2 2026 reduction was Intel, cutting an estimated $44.3M.
- Philip James Wealth Mangement fully exited Organon & Co in Q2 2026, selling an estimated $604K.
- Philip James Wealth Mangement's ten largest holdings make up 54% of its $888M portfolio in Q2 2026.
- Philip James Wealth Mangement opened 10 new positions and closed 16 in Q2 2026.
- Philip James Wealth Mangement's portfolio value rose 2.2% quarter-over-quarter to $888M.
Based on Philip James Wealth Mangement's 13F filing for Q2 2026, filed 27 Jul 2026.